1673-422X
2011 Issue 7
Dendritic cells in breast cancer therapy
MA Teng;LI Bao-jiang;YE Xin
MA Teng;LI Bao-jiang;YE Xin
..............page:521-524
Clinicopathological characteristics and prognostic factors of hepatoid adenocarcinoma of stomach
KONG Da-lu
KONG Da-lu
..............page:545-547
Regulatory T cells and tumor
YANG Ji-yuan;DU Wei
YANG Ji-yuan;DU Wei
..............page:496-498
ATM and resistance of gliomas to chemotherapy and radiotherapy
ZHEN Shi-ming;YANG li-juan;LIN Zhi-xiong
ZHEN Shi-ming;YANG li-juan;LIN Zhi-xiong
..............page:506-509
Relationship between tumor tolerance to TRAIL and its receptors
OUYANG Wen;XIE Cong-hua
OUYANG Wen;XIE Cong-hua
..............page:483-485
Hypoxia inducible factor-la and colorectal cancer
CI Shu-jun;ZHOU Li-hong;LI Qi
CI Shu-jun;ZHOU Li-hong;LI Qi
..............page:547-550
Important trials of targeted therapy in patients with advanced gastric carcinoma
ZHANG Bai-hong;WANG Xiang-hui
ZHANG Bai-hong;WANG Xiang-hui
..............page:543-544
miR-200 family and its mechanism
SU Juan;ZHANG Qing-yu
SU Juan;ZHANG Qing-yu
..............page:486-489
Therapy for brain metastasis from non-small cell lung cancer
ZENG Yin-duo;DING\' LIN Xiao-xiao;CHEN Li-kun
ZENG Yin-duo;DING\' LIN Xiao-xiao;CHEN Li-kun
..............page:537-540
..............page:558-560
Endoscopic ultrasonography in gastric cancer: from diagnosis to therapy
HUANG Chun-yu;WANG Wei;ZHOU Zhi-wei
HUANG Chun-yu;WANG Wei;ZHOU Zhi-wei
..............page:540-542
Metronomic chemotherapy and breast cancer
SHI Li-li;MOU Lin;LI Li
SHI Li-li;MOU Lin;LI Li
..............page:524-527
Aberrant methylation in lung cancer
HU Lin;SU Dan;ZHANG Yi-ping
HU Lin;SU Dan;ZHANG Yi-ping
..............page:533-536
Tamoxifen and fatty fiver disease
SHEN Jie;HE Sheng-li
SHEN Jie;HE Sheng-li
..............page:529-532
Mechanism of anti-tumor effects of resveratrol
MENG De-ping;XU Xiao-qun;WANG Jun-fu
MENG De-ping;XU Xiao-qun;WANG Jun-fu
..............page:489-492
Analysis of the proliferation ability and the antineoplastic activity of CIK cells against original hepatocellullar cancer cells between healthy adults and tumor patients
YAO Gen-dong;HUO Hong-qi;LI Peng;LIU Ai-min
YAO Gen-dong;HUO Hong-qi;LI Peng;LIU Ai-min
..............page:555-558
Sequential DC-CIK and radix astragali polysaccharide in post-chemotherapy breast cancer patients
ZHANG Xiao-bing;LIU Jian
ZHANG Xiao-bing;LIU Jian
..............page:527-529
Wnt signaling pathway and osteosarcoma
TAO Ke;XIONG Ao;ZENG Hui
TAO Ke;XIONG Ao;ZENG Hui
..............page:551-554
Circulating tumor cells in breast cancer
HUANG Hong-yan;JIANG Ze-fei
HUANG Hong-yan;JIANG Ze-fei
..............page:516-518
A new anti-cancer target: ADAM10
PAN Yuan;DING Xue-hua
PAN Yuan;DING Xue-hua
..............page:492-495
Dose-effect of HIFU in tumor therapy
RUAN Wei-wei;WANG Shan
RUAN Wei-wei;WANG Shan
..............page:503-505
Quality of life scale in esophageal carcinoma surgical treatment
LIANG Ming-qiang;TAN Li-jie
LIANG Ming-qiang;TAN Li-jie
..............page:513-515
Lymphangiogenesis factor in the lymph node metastasis of head and neck cancer
SUN Shu-jun;ZHAO Li-min;ZHOU Jian-ming
SUN Shu-jun;ZHAO Li-min;ZHOU Jian-ming
..............page:509-512
Nutritional prevention of breast cancer
OU Jun-wen
OU Jun-wen
..............page:519-521
Clinical progress of measuring tumor cell proliferation with 18F-FLT PET
CHEN Zhong-jie;YU Jin-ming
CHEN Zhong-jie;YU Jin-ming
..............page:499-502